Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’
Researchers still think patients should receive an injectable version of semaglutide when possible, but new data out of ACC.25 confirm that an oral formulation of the drug is associated with significant benefits.
‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
A glass of orange juice a day may help keep the cardiologist away
Drinking orange juice is associated with several interactions in the body that may help combat the risks of cardiac remodeling.
Opportunistic screening: AI highlights key heart findings in mammography images
Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.

1 in 5 kids estimated to have high blood pressure

Some 20% of children have high blood pressure, WBAL-TV reported Feb. 17.

Psychologist uses beta-blockers to ease patients’ emotional pain

A Canadian clinical psychologist is repurposing a beta-blocker to ease the pain of emotional trauma, the BBC reports.

Diabetes drug rosiglitazone linked—again—to poor CV health

Research out of the Yale School of Public Health in New Haven, Conn., has revealed a relationship between rosiglitazone, a type 2 diabetes drug, and heart disease.

FDA grants breakthrough status to pulmonary hypertension solution

The U.S. FDA on Feb. 6 granted Breakthrough Device Designation to medical device developer Aria CV, Inc., for its Aria CV Pulmonary Hypertension System.

Initiating antihypertensives, statins increases likelihood of obesity

People who begin taking antihypertensive drugs or lipid-lowerers like statins are more likely than non-initiators to become obese and physically inactive, a JAHA study has found—but they’re also more likely to quit smoking and keep their alcohol intake in check.

BP variability in young adulthood linked to CV ills later in life

Higher visit-to-visit systolic blood pressure variability early in life may predict CVD and all-cause mortality in middle age, according to research published in JAMA Cardiology on Jan. 22.

Following controversial guideline, another study connects meat consumption to CVD

Another study has surfaced suggesting that meat—both processed and unprocessed—can have deleterious effects on heart health.

Why VA physicians are writing ‘farmacy’ prescriptions for food, not meds

Patients in Massachusetts may soon be receiving “farmacy” prescriptions in lieu of traditional pharmacy scripts.

Heart Health

Plant-based diets may help patients with diabetes, heart disease live longer

Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

A glass of orange juice a day may help keep the cardiologist away

Opportunistic screening: AI highlights key heart findings in mammography images